News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,708 Results
Type
Article (42095)
Company Profile (271)
Press Release (691326)
Multimedia
Podcasts (91)
Webinars (21)
Section
Business (205634)
Career Advice (2049)
Deals (35635)
Drug Delivery (129)
Drug Development (81661)
Employer Resources (173)
FDA (16547)
Job Trends (15047)
News (347909)
Policy (32854)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2642)
Academic (1)
Accelerated approval (47)
Adcomms (26)
Allergies (171)
Alliances (49878)
ALS (211)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (444)
Approvals (16923)
Artificial intelligence (661)
Autoimmune disease (291)
Automation (56)
Bankruptcy (364)
Best Places to Work (11664)
BIOSECURE Act (20)
Biosimilars (220)
Biotechnology (179)
Bladder cancer (188)
Brain cancer (71)
Breast cancer (747)
Cancer (5796)
Cardiovascular disease (468)
Career advice (1738)
Career pathing (43)
CAR-T (332)
CDC (56)
Celiac Disease (3)
Cell therapy (898)
Cervical cancer (47)
Clinical research (70882)
Collaboration (2052)
Company closure (5)
Compensation (1389)
Complete response letters (79)
COVID-19 (2756)
CRISPR (108)
C-suite (1116)
Cystic fibrosis (152)
Data (7856)
Decentralized trials (3)
Denatured (27)
Depression (161)
Dermatology (86)
Diabetes (587)
Diagnostics (6954)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (317)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92171)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119857)
Executive appointments (1079)
FDA (20255)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1729)
Gene editing (234)
Generative AI (56)
Gene therapy (720)
GLP-1 (1052)
Government (4758)
Grass and pollen (6)
Guidances (408)
Healthcare (19026)
HIV (80)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (287)
Immuno-oncology (92)
Indications (191)
Infectious disease (3097)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (288)
Interviews (322)
IPO (16683)
IRA (50)
Job creations (3684)
Job search strategy (1443)
JPM (58)
Kidney cancer (19)
Labor market (101)
Layoffs (565)
Leadership (41)
Legal (7971)
Liver cancer (100)
Longevity (32)
Lung cancer (762)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1044)
MASH (187)
Medical device (13959)
Medtech (14080)
Mergers & acquisitions (20195)
Metabolic disorders (1496)
mRNA (207)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (415)
Neuropsychiatric disorders (105)
Neuroscience (3307)
Neurotech (1)
NextGen: Class of 2026 (6541)
Non-profit (4559)
Now hiring (78)
Obesity (698)
Opinion (286)
Ovarian cancer (219)
Pain (252)
Pancreatic cancer (299)
Parkinson's disease (361)
Partnered (33)
Patents (592)
Patient recruitment (669)
Peanut (62)
People (59875)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22122)
Phase 2 (31225)
Phase 3 (23224)
Pipeline (8693)
Policy (317)
Postmarket research (2573)
Preclinical (9434)
Press Release (68)
Prostate cancer (299)
Psychedelics (54)
Radiopharmaceuticals (320)
Rare diseases (1071)
Real estate (6030)
Recruiting (70)
Regulatory (25441)
Reports (56)
Research institute (2455)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (291)
Series B (214)
Service/supplier (11)
Sickle cell disease (112)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3664)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (88)
The Weekly (62)
Vaccines (1095)
Venture capital (108)
Weight loss (450)
Women's health (125)
Worklife (20)
Date
Today (123)
Last 7 days (852)
Last 30 days (3576)
Last 365 days (30205)
2026 (12415)
2025 (30220)
2024 (35256)
2023 (40136)
2022 (51244)
2021 (55807)
2020 (54205)
2019 (46686)
2018 (35173)
2017 (32277)
2016 (31672)
2015 (37786)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (746)
Alabama (94)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39904)
Australia (6542)
California (13254)
Canada (3764)
China (1335)
Colorado (566)
Connecticut (577)
Delaware (404)
Europe (86343)
Florida (1984)
Georgia (426)
Hawaii (3)
Idaho (62)
Illinois (1051)
India (90)
Indiana (599)
Iowa (23)
Japan (535)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1587)
Massachusetts (9455)
Michigan (362)
Minnesota (715)
Mississippi (7)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (84)
New Jersey (3486)
New Mexico (29)
New York (3466)
North Carolina (1679)
North Dakota (9)
Northern California (6644)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2666)
Puerto Rico (29)
Rhode Island (50)
South America (1121)
South Carolina (85)
South Dakota (2)
Southern California (5228)
Tennessee (212)
Texas (2105)
United States (46752)
Utah (393)
Vermont (1)
Virginia (324)
Washington D.C. (80)
Washington State (1062)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
733,708 Results for "clearside biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
August 27, 2025
·
7 min read
Press Releases
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
July 23, 2025
·
4 min read
Press Releases
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
June 18, 2025
·
6 min read
BioMidwest
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.
June 12, 2024
·
7 min read
Press Releases
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
May 21, 2025
·
1 min read
Press Releases
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
May 2, 2025
·
1 min read
Press Releases
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
·
8 min read
Press Releases
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
April 5, 2026
·
1 min read
Business
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Clearside Biomedical, Inc. announced that Anthony S. Gibney has been appointed to the Company’s Board of Directors, effective April 15, 2024.
April 16, 2024
·
5 min read
Press Releases
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
May 9, 2025
·
1 min read
1 of 73,371
Next
